This compound is a modified nucleoside used as a building block in oligonucleotide synthesis. It features a purine base with an isobutyramide protecting group and a dimethoxytrityl (DMT) protecting group on the sugar moiety, which is typical for solid-phase DNA/RNA synthesis.
Escopo do conteúdo: As informações desta página dizem respeito à identificação química e aos contextos de fornecimento industrial, pesquisa e produção. Não constituem alegação terapêutica, aconselhamento médico ou instruções de uso de medicamentos.
Adquirindo ou fornecendo este composto?
Publique seu inventário ou uma solicitação de compra
CAS 114745-26-5
5'-O-[Bis(4-methoxyphenyl)phenylmethyl]-2'-O-(2-methoxyethyl)-N-(2-methyl-1-oxopropyl)guanosine
nucleoside analog pharmaceutical intermediate
5'-O-DMT-2'-O-iBu-N-Bz-Guanosine
protected guanosine for oligonucleotide synthesis
N-(9-((2R,3R,4R,5R)-5-((Bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-3-fluoro-4-hydroxytetrahydrofuran-2-yl)-6-oxo-6,9-dihydro-1H-purin-2-yl)isobutyramide
Pharmaceutical intermediate for oligonucleotide synthesis
Guanosine, 5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-N-(2-methyl-1-oxopropyl)-
Protected nucleotide building block for oligonucleotide synthesis
[1,1'-Biphenyl]-2-carboxylic acid, 4'-methyl-, methyl ester
pharmaceutical intermediate
Methyl 4'-(Bromomethyl)biphenyl-2-carboxylate
pharmaceutical intermediate
TERT-BUTYL 4'-(BROMOMETHYL)BIPHENYL-2-CARBOXYLATE
pharmaceutical intermediate
2-Cyano-4'-methylbiphenyl
pharmaceutical intermediate
N-[9-[(2R,3R,4R,5R)-5-[[bis(4-methoxyphenyl)-phenylmethoxy]methyl]-4-hydroxy-3-methoxyoxolan-2-yl]-6-oxo-1H-purin-2-yl]-2-methylpropanamide
ISQLJOGRNUQHJX-WIFIACMTSA-N
CC(C)C(=O)NC1=NC2=C(C(=O)N1)N=CN2[C@H]3[C@@H]([C@@H]([C@H](O3)COC(C4=CC=CC=C4)(C5=CC=C(C=C5)OC)C6=CC=C(C=C6)OC)O)OC